TL;DR: KF 15232 (CAS 124294-43-5) is a chemical compound with molecular formula C20H19N5O and molecular weight 345.15897 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
3-[4-(benzylamino)quinazolin-7-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one
Also Known As: KF 15232, KF 15832, 4,5-Dihydro-5-methyl-6-(4-((phenylmethyl)amino)-7-quinazolinyl)-3(2H)-pyridazinone, 3-[4-(benzylamino)quinazolin-7-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one, 3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-(4-((phenylmethyl)amino)-7-quinazolinyl)-
Top 5 of 1 IPC patent classification(s) from the SureChEMBL global patent database.
| Molecular Formula | C20H19N5O |
| Molecular Weight | 345.15897 g/mol |
| XLogP | 2.9 |
| Topological Polar Surface Area (TPSA) | 79.3 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Exact Mass | 345.15897 Da |
| Heavy Atoms | 26 |
| Complexity | 530.0 |
| SMILES | CC1CC(=O)NN=C1C2=CC3=C(C=C2)C(=NC=N3)NCC4=CC=CC=C4 |
| InChIKey | KJCLPXFGPVCAKL-UHFFFAOYSA-N |
The XLogP value of 2.9 suggests moderate lipophilicity, balancing water solubility and membrane permeability for KF 15232. The TPSA of 79.3 Ų falls within the moderate polarity range, balancing permeability and solubility for KF 15232. Following Lipinski's Rule of Five, KF 15232 has 2 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of KF 15232 is 124294-43-5.
The molecular formula of KF 15232 is C20H19N5O.
The molecular weight of KF 15232 is 345.15897 g/mol.
You can request a quote for KF 15232 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for KF 15232 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 124294-43-5. Our professional technical team will respond with pricing and lead time.